Abstract
Using standard transurethral electrosurgical technology, electrovaporization has quickly become a popular procedure for treating benign prostatic hyperplasia. It offers standard transurethral loop-like resection or transurethral resection-like efficacy without significant morbidities associated with the latter procedure. By combining two electrosurgical effects, vaporization and desiccation, into one motion, electrovaporization has the potential to surpass the standard transurethral resection as a gold standard. This review examines the clinical and technical advances developed in optimizing the surgical outcome of an electrovaporative resection. In addition to a review of ongoing clinical investigations by several institutions, an analysis of factors affecting electrovaporization and the subsequent refinement of technology resulting in new generators, surgical techniques, and electrode configurations are reported.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
